1. Home
  2. TNON vs REVB Comparison

TNON vs REVB Comparison

Compare TNON & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenon Medical Inc.

TNON

Tenon Medical Inc.

HOLD

Current Price

$4.52

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

N/A

Current Price

$1.02

Market Cap

3.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TNON
REVB
Founded
2012
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.9M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
TNON
REVB
Price
$4.52
$1.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.1M
37.7K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
84.90
72.68
EPS
N/A
N/A
Revenue
$3,944,000.00
N/A
Revenue This Year
$65.95
N/A
Revenue Next Year
$50.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
20.35
N/A
52 Week Low
$0.13
$0.47
52 Week High
$17.84
$2.90

Technical Indicators

Market Signals
Indicator
TNON
REVB
Relative Strength Index (RSI) 51.70 44.12
Support Level $0.56 $0.94
Resistance Level $7.15 $1.21
Average True Range (ATR) 1.29 0.08
MACD -0.37 -0.01
Stochastic Oscillator 0.86 31.86

Price Performance

Historical Comparison
TNON
REVB

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

Share on Social Networks: